GeneDx Holdings Corp.
For the period ended Dec 31, 2025. Filed Feb 23, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 23, 2026
WGS$54.83-16.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Financial Statements and Supplementary Data
| Report of Independent Registered Public Accounting Firm (PCAOB ID 42) | 68 |
|---|---|
| Consolidated Financial Statements: | |
| Consolidated Balance Sheets | 70 |
| Consolidated Statements of Operations and Comprehensive Loss | 71 |
| Consolidated Statements of Stockholders' Equity | 72 |
| Consolidated Statements of Cash Flows | 73 |
| Notes to Consolidated Financial Statements | 74 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.